203 related articles for article (PubMed ID: 1592998)
1. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision.
Silverman MK; Kopf AW; Bart RS; Grin CM; Levenstein MS
J Dermatol Surg Oncol; 1992 Jun; 18(6):471-6. PubMed ID: 1592998
[TBL] [Abstract][Full Text] [Related]
2. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
Silverman MK; Kopf AW; Grin CM; Bart RS; Levenstein MJ
J Dermatol Surg Oncol; 1991 Sep; 17(9):720-6. PubMed ID: 1820764
[TBL] [Abstract][Full Text] [Related]
3. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy.
Silverman MK; Kopf AW; Gladstein AH; Bart RS; Grin CM; Levenstein MJ
J Dermatol Surg Oncol; 1992 Jul; 18(7):549-54. PubMed ID: 1624628
[TBL] [Abstract][Full Text] [Related]
4. Recurrence rates of treated basal cell carcinomas. Part 1: Overview.
Silverman MK; Kopf AW; Grin CM; Bart RS; Levenstein MJ
J Dermatol Surg Oncol; 1991 Sep; 17(9):713-8. PubMed ID: 1890243
[TBL] [Abstract][Full Text] [Related]
5. Whole specimen intraoperative frozen section analysis. Experience with 1082 basal cell carcinomas.
Kedilioglu MA; Bos PG; De Jong K; Noordzij NA; Kibbelaar RE; Lapid O; Mouës CM
Eur J Surg Oncol; 2018 Jan; 44(1):157-162. PubMed ID: 29198817
[TBL] [Abstract][Full Text] [Related]
6. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
[TBL] [Abstract][Full Text] [Related]
7. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of basal cell carcinoma amongst Asians in Singapore and a comparison between completely and incompletely excised tumors.
Goh BK; Ang P; Wu YJ; Goh CL
Int J Dermatol; 2006 May; 45(5):561-4. PubMed ID: 16700792
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of incompletely excised basal cell carcinomas of the skin.
Rippey JJ; Rippey E
Med J Aust; 1997 Jun; 166(11):581-3. PubMed ID: 9201177
[TBL] [Abstract][Full Text] [Related]
10. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
11. Eradication of basal cell carcinoma of the head and neck using the surgical excision with a new stained margin technique: a preliminary study.
Celasco M; Zavattaro E; Veronese F; Boggio P; Bonvini D; Leigheb G; Valente G; Colombo E
G Ital Dermatol Venereol; 2018 Oct; 153(5):624-631. PubMed ID: 28509524
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
Spraul CW; Ahr WM; Lang GK
Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Pigmented Basal Cell Carcinoma with 3 mm Surgical Margin in Asians.
Lin SH; Cheng YW; Yang YC; Ho JC; Lee CH
Biomed Res Int; 2016; 2016():7682917. PubMed ID: 27652267
[TBL] [Abstract][Full Text] [Related]
14. Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management.
Codazzi D; Van Der Velden J; Carminati M; Bruschi S; Bocchiotti MA; Di Serio C; Barberis M; Robotti E
J Plast Surg Hand Surg; 2014 Feb; 48(1):38-43. PubMed ID: 23731130
[TBL] [Abstract][Full Text] [Related]
15. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features.
Mertz KD; Proske D; Kettelhack N; Kegel C; Keusch G; Schwarz A; Ambühl PM; Pfaltz M; Kempf W
Int J Dermatol; 2010 Apr; 49(4):385-9. PubMed ID: 20465691
[TBL] [Abstract][Full Text] [Related]
16. Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients.
Kricker A; Armstrong B; Hansen V; Watson A; Singh-Khaira G; Lecathelinais C; Goumas C; Girgis A
J Am Acad Dermatol; 2014 Mar; 70(3):456-64. PubMed ID: 24373780
[TBL] [Abstract][Full Text] [Related]
17. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
Blixt E; Nelsen D; Stratman E
Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
[TBL] [Abstract][Full Text] [Related]
18. Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
Nemet AY; Deckel Y; Martin PA; Kourt G; Chilov M; Sharma V; Benger R
Am J Ophthalmol; 2006 Aug; 142(2):293-7. PubMed ID: 16876511
[TBL] [Abstract][Full Text] [Related]
19. Follow-up of basal cell carcinomas: an audit of current practice.
Mc Loone NM; Tolland J; Walsh M; Dolan OM
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):698-701. PubMed ID: 16836498
[TBL] [Abstract][Full Text] [Related]
20. Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions.
Bartoš V; Pokorný D; Zacharová O; Haluska P; Doboszová J; Kullová M; Adamicová K; Péč M; Péč J
Acta Dermatovenerol Alp Pannonica Adriat; 2011 Jun; 20(2):67-75. PubMed ID: 21993704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
